IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. More...

Full description

Bibliographic Details
Main Authors: Milica M. Borovcanin, Slavica M. Janicijevic, Ivan P. Jovanovic, Nevena Gajovic, Nebojsa N. Arsenijevic, Miodrag L. Lukic
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Psychiatry
Subjects:
schizophrenia
galectin-3
interleukin-33
metabolic syndrome
cardiovascular issues
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00271/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2018.00271/full

Similar Items